Skip to main content
OpenTrials

Clinical trial condition

Nasopharyngeal Diseases

Explore clinical trials studying Nasopharyngeal Diseases. Study availability and eligibility vary by location and protocol.

489 public trials 162 recruiting studies
Refine in advanced search Browse all conditions

Nasopharyngeal Diseases trial results

Completed

Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)

NCT03924986

Conditions
Disease Attributes, Head and Neck Neoplasms, Nasopharyngeal Diseases, +12 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Chongqing Three Gorges Central Hospital Chongqing, Chongqing Municipality, China
View all 37 locations
View Trial Details
Completed

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

NCT03674567

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +44 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles JCCC Clinical Research Unit Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 35 locations
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

NCT03474640

Conditions
Adenocarcinoma, Advanced Malignancies, Carcinoma, +28 more
Locations
  • Sarcoma Oncology Research Center Santa Monica, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • University of Miami Hospital Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 14 locations
View Trial Details

Related conditions